Publicador de contenidos

LIVERAIM

A biomarker-based platform for early diagnosis of chronic liver disease to enable personalised therapy

Duración
01/03/2024 - 28/02/2029
Coordinador
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
Financiadores
Innovative Health Initiative Joint Undertaking (IHI JU), European Union’s Horizon Europe research and innovation programme, EFPIA, COCIR, MedTech Europe, Vaccines Europe and EuropaBio.

Innovative Health Initiative-funded project LIVERAIM aims to create and validate a biomarker-based screening platform to enable early detection of liver disease in asymptomatic individuals, allowing for personalised and effective therapeutic interventions to halt or reverse disease progression.

It brings together the top academic researchers in the field of liver disease, industry partners from both the biomarker and pharmaceutical industries, patient associations, leading health economists, public health experts and AI tool creators to form the LIVERAIM consortium.

Total Funding

24.800.000€

 

Nuestro equipo

Equipo ISGlobal

Ver más